Business Context and Reporting Period
This Form 8-K is a current report filed by Enochian Biosciences, Inc. (trading symbol: ENOB) on November 26, 2019. The filing discloses the execution of binding agreements for a capital raise effective November 14, 2019. Note: The request metadata references "Lunai Bioworks Inc.", but the filing text explicitly identifies the registrant as Enochian Biosciences, Inc.
Key Financial Metrics and Transaction Details
The filing details a financing transaction structured in two components:
- Equity Component: Agreement to purchase 900,000 shares of Common Stock at $12.00 per share, totaling $10,800,000.
- Debt Component: Agreement to purchase a convertible promissory note for $1,200,000, convertible into 100,000 shares of Common Stock at $12.00 per share.
- Total Aggregate Purchase Price: $12,000,000.
The filing does not provide historical revenue, profit, cash flow, or existing debt levels. It focuses solely on the terms of this new financing.
Material Changes and Closing Conditions
The primary material change is the commitment of $12 million in new capital, subject to closing conditions. The transaction is split into two closing schedules:
- Note Purchase Agreement: Scheduled to close on or before December 21, 2019.
- Securities Purchase Agreement: Scheduled to close on or before March 31, 2020.
Outlook, Risks, and Management Commentary
Management has not provided specific operational guidance or outlook in this filing. The document serves as a disclosure of the executed agreements. The primary risk noted is that the agreements are binding but subject to certain closing conditions; therefore, the capital is not guaranteed until the specified closing dates are met and conditions are satisfied.
Investor Verification Checklist
- Verify the current stock price relative to the $12.00 per share purchase price in the agreement.
- Confirm the specific "closing conditions" detailed in the attached Securities Purchase Agreement (Exhibit 99.1) and Note Purchase Agreement (Exhibit 99.2).
- Monitor the closing status of the Note Purchase Agreement by the December 21, 2019 deadline.
- Review the full text of the Convertible Promissory Note (Exhibit 99.3) for interest rates, maturity dates, and conversion mechanics.